- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
CELL DEATH IN THE OLFACTORY SYSTEM |
199 |
REFERENCES
Altman J. Autoradiographic and histological studies of postnatal neurogenesis (1969) IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol. 137(4):433–57.
Alvarez-Buylla A, Garc´ıa-Verdugo JM, Tramontin AD (2001) A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci. 2(4):287–93.
Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson’s disease. J Chronic Dis. 28(9):493–7.
Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, Lloyd KC, Lai C (2004) Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci. 7(12):1319–28.
Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. J Neural Transm Suppl. 53: 127–40.
Braak H, Del Tredici K, Rub¨ U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 24(2):197–211.
Brazel CY, Nunez˜ JL, Yang Z, Levison SW (2005) Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone. Neuroscience.
131(1):55–65.
Caggiano M, Kauer JS, Hunter DD (1994) Globose basal cells are neuronal progenitors in the olfactory epithelium: a lineage analysis using a replication-incompetent retrovirus. Neuron.
13(2):339–52.
Corotto FS, Henegar JR, Maruniak JA (1994) Odor deprivation leads to reduced neurogenesis and reduced neuronal survival in the olfactory bulb of the adult mouse. Neuroscience.
61(4):739–44.
Cowan CM, Thai J, Krajewski S, Reed JC, Nicholson DW, Kaufmann SH, Roskams AJ (2001) Caspases 3 and 9 send a proapoptotic signal from synapse to cell body in olfactory receptor neurons. J Neurosci. 21(18):7099–109.
Cowan CM, Roskams AJ (2002) Apoptosis in the mature and developing olfactory neuroepithelium. Microsc Res Tech.
58(3):204–15.
Cowan CM, Roskams AJ (2004) Caspase-3 and caspase-9 mediate developmental apoptosis in the mouse olfactory system.
J Comp Neurol. 474(1):136–48.
Cremer H, Lange R, Christoph A, Plomann M, Vopper G, Roes J, Brown R, Baldwin S, Kraemer P, Scheff S, et al. (1994) Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature. 367(6462):455–9.
Crino PB, Martin JA, Hill WD, Greenberg B, Lee VM, Trojanowski JQ (1995) Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease, Parkinson’s disease, and Down syndrome. Ann Otol Rhinol Laryngol. 104(8):655–61.
Daniel SE, Hawkes CH (1992) Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology. Lancet.
340(8812):186.
Deckner ML, Risling M, Frisen´ J (1997) Apoptotic death of olfactory sensory neurons in the adult rat. Exp Neurol. 143(1):132– 40.
Doetsch F, Garc´ıa-Verdugo JM, Alvarez-Buylla A (1999) Regeneration of a germinal layer in the adult mammalian brain. Proc Natl Acad Sci U S A. 96(20):11619–24.
Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L (1984) Smell identification ability: changes with age. Science. 226(4681):1441–3.
Enwere E, Shingo T, Gregg C, Fujikawa H, Ohta S, Weiss S (2004) Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. J Neurosci. 24(38):8354–65.
Farbman AI (1990) Olfactory neurogenesis: genetic or environmental controls? Trends Neurosci. 13(9):362–5.
Farbman AI, Brunjes PC, Rentfro L, Michas J, Ritz S (1988) The effect of unilateral naris occlusion on cell dynamics in the developing rat olfactory epithelium. J Neurosci. 8(9):3290–5.
Farbman AI, Buchholz JA, Suzuki Y, Coines A, Speert D (1999) A molecular basis of cell death in olfactory epithelium. J Comp Neurol. 414(3):306–14.
Gage FH (2002) Neurogenesis in the adult brain. J Neurosci.
22(3):612–3.
Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV (2004) GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci.
7(11):1233–41.
Gascon E, Vutskits L, Jenny B, Durbec P, Kiss JZ (2007) PSANCAM in postnatally generated immature neurons of the olfactory bulb: a crucial role in regulating p75 expression and cell survival. Development. 134(6):1181–90.
Gheusi G, Cremer H, McLean H, Chazal G, Vincent JD, Lledo PM (2000) Importance of newly generated neurons in the adult olfactory bulb for odor discrimination. Proc Natl Acad Sci U S A. 97(4):1823–8.
Gould E (2007) How widespread is adult neurogenesis in mammals? Nat Rev Neurosci. 8(6):481–8.
Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB (1999) Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology. 53(7):1480–7
Graziadei PP (1973) Cell dynamics in the olfactory mucosa.
Tissue Cell. 5(1):113–31.
Graziadei PP, Monti Graziadei GA (1980) Neurogenesis and neuron regeneration in the olfactory system of mammals. III. Deafferentation and reinnervation of the olfactory bulb following section of the fila olfactoria in rat. J Neurocytol.
9(2):145–62.
Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, AsheryPadan R, Lledo PM, Gotz¨ M (2005) Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci. 8(7): 865–72.
Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord. 22(6):839–42.
Hawkes C (2006) Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol. 63:133–51.
200 |
PAWEL KERMER |
Hinds JW, Hinds PL, McNelly NA (1984) An autoradiographic study of the mouse olfactory epithelium: evidence for longlived receptors. Anat Rec. 210(2):375–83.
Holcomb JD, Mumm JS, Calof AL (1995) Apoptosis in the neuronal lineage of the mouse olfactory epithelium: regulation in vivo and in vitro. Dev Biol. 172(1):307–23.
Jourdan F, Moyse E, De Bilbao F, Dubois-Dauphin M (1998) Olfactory neurons are protected from apoptosis in adult transgenic mice over-expressing the bcl-2 gene. Neuroreport
9(5):921–6.
Kim WR, Kim Y, Eun B, Park OH, Kim H, Kim K, Park CH, Vinsant S, Oppenheim RW, Sun W (2007) Impaired migration in the rostral migratory stream but spared olfactory function after the elimination of programmed cell death in Bax knock-out mice. J Neurosci. 27(52):14392–403.
Kovacs´ T, Cairns NJ, Lantos PL (2001) Olfactory centres in Alzheimer’s disease: olfactory bulb is involved in early Braak’s stages. Neuroreport 12(2):285–8.
Li L, Liu F, Salmonsen RA, Turner TK, Litofsky NS, Di Cristofano A, Pandolfi PP, Jones SN, Recht LD, Ross AH (2002) PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci. 20(1):21–9.
Lledo PM, Saghatelyan A (2005) Integrating new neurons into the adult olfactory bulb: joining the network, life-death decisions, and the effects of sensory experience. Trends Neurosci.
28(5):248–54.
Lledo PM, Alonso M, Grubb MS (2006) Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci.
7(3):179–93.
Lois C, Garc´ıa-Verdugo JM, Alvarez-Buylla A (1996) Chain migration of neuronal precursors. Science. 271(5251):978– 81.
Mackay-Sim A, Kittel P (1991) Cell dynamics in the adult mouse olfactory epithelium: a quantitative autoradiographic study.
J Neurosci. 11(4):979–84.
Magrassi L, Graziadei PP (1995) Cell death in the olfactory epithelium. Anat Embryol (Berl). 192(1):77–87.
Miwa N, Storm DR (2005) Odorant-induced activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in the olfactory bulb promotes survival of newly formed granule cells. J Neurosci. 25(22):5404–12.
Pellier V, Astic L (1994) Cell death in the developing olfactory epithelium of rat embryos. Brain Res Dev Brain Res. 79(2): 307–15.
Petreanu L, Alvarez-Buylla A (2002) Maturation and death of adult-born olfactory bulb granule neurons: role of olfaction.
J Neurosci. 22(14):6106–13.
Robinson AM, Conley DB, Shinners MJ, Kern RC (2002) Apoptosis in the aging olfactory epithelium. Laryngoscope. 112 (8 Pt 1):1431–5.
Robinson AM, Conley DB, Kern RC (2003) Olfactory neurons in bax knockout mice are protected from bulbectomy-induced apoptosis. Neuroreport. 14(15):1891–4.
Rochefort C, Gheusi G, Vincent JD, Lledo PM (2002) Enriched odor exposure increases the number of newborn neurons in
the adult olfactory bulb and improves odor memory. J Neurosci. 22(7):2679–89.
Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 21(12):2062–7.
Saghatelyan A, Roux P, Migliore M, Rochefort C, Desmaisons D, Charneau P, Shepherd GM, Lledo PM (2005) Activitydependent adjustments of the inhibitory network in the olfactory bulb following early postnatal deprivation. Neuron.
46(1):103–16.
Sanai N, Tramontin AD, Quinones˜-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garc´ıa Verdugo J, Berger MS, Alvarez-Buylla A (2004) Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature.
427(6976):740–4.
Schwob JE, Szumowski KE, Stasky AA (1992) Olfactory sensory neurons are trophically dependent on the olfactory bulb for their prolonged survival. J Neurosci. 12(10):3896–919.
Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord. 19(10):1196–202.
Stevens JC, Cain WS (1987) Old-age deficits in the sense of smell as gauged by thresholds, magnitude matching, and odor identification. Psychol Aging. 2(1):36–42.
Suzuki Y (2004) Fine structural aspects of apoptosis in the olfactory epithelium. J Neurocytol. 33(6):693–702.
Suzuki Y, Farbman AI (2000) Tumor necrosis factor-alpha- induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32). Exp Neurol. 165(1):35–45.
Suzuki Y, Takeda M (1991) Basal cells in the mouse olfactory epithelium after axotomy: immunohistochemical and electron-microscopic studies. Cell Tissue Res. 266(2):239–45.
Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS (1989) Pathological changes in olfactory neurons in patients with Alzheimer’s disease. Nature. 337(6209):736–9.
Tomasiewicz H, Ono K, Yee D, Thompson C, Goridis C, Rutishauser U, Magnuson T (1993) Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron.
11(6):1163–74.
Winner B, Cooper-Kuhn CM, Aigner R, Winkler J, Kuhn HG (2002) Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb. Eur J Neurosci.
16(9):1681–9.
Yamada M, Onodera M, Mizuno Y, Mochizuki H (2004) Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated adult mice. Neuroscience. 124(1):173–81.
Yamagishi M, Ishizuka Y, Seki K (1994) Pathology of olfactory mucosa in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol. 103(6):421–7.
19 Contribution of Apoptosis to Physiologic
Remodeling of the Endocrine Pancreas and Pathophysiology of Diabetes
Nika N. Danial
1. INTRODUCTION
Homeostatic control of blood glucose levels is critically dependent on the balance of glucagon and insulin, two counteracting pancreatic hormones secreted by endocrine cells within the islets of Langerhans – alpha and beta cells, respectively. Elegant biochemical studies combined with metabolic flux analysis uncovered the unique ability of beta cells to sense blood glucose fluctuations and to fine tune insulin secretion accordingly.1 A high-capacity glucose transport system, a low-Km glucose phosphorylating activity catalyzed by glucokinase (GK), and the ability to channel the majority of glycolytically derived pyruvate to the mitochondrial tricarboxylic acid (TCA) cycle constitute essential metabolic design features that endow beta cells with a specialized secretory function.2 The increase in intracellular adenosine triphosphate (ATP)/adenosine diphosphate (ADP) ratio on mitochondrial metabolism of nutrients is among the metabolic coupling factors connecting fuel oxidation to insulin secretion. A rise in ATP/ADP ratio in turn leads to closure of ATP-sensitive K (KATP) channels at the plasma membrane, followed by membrane depolarization and influx of Ca2+ necessary for release of insulin granules.3 The two aspects of beta cell biology that contribute significantly to euglycemia are glucose dose responsiveness of insulin secretion and the remarkable plasticity of beta cell mass to meet insulin demand under physiologic and pathophysiologic nutrient stress.4,5 Beta cell mass is the net outcome of neogenesis (formation of new beta cells from non–beta cell precursors), replication of preexisting beta cells, beta cell size, and apoptosis.6 The integration of beta cell function and mass is further ensured through nutrient sensing pathways that concomitantly signal insulin secretion and modulate beta cell replication and survival.7,8 This chapter highlights the
apoptotic mechanisms operative in beta cells that influence the dynamic control of beta cell mass during the developmental remodeling of the endocrine pancreas and in the pathogenesis of diabetes.
2. APOPTOSIS IN PHYSIOLOGIC CONTROL
OF BETA CELL MASS
The transition from fetal to adult beta cell during physiologic remodeling of endocrine pancreas is heavily influenced by apoptosis. During fetal life in both rodents and humans, large and rapid expansion of beta cell mass is marked mainly by beta cell neogenesis, endowing the fetal pancreas with a suitable number of beta cells.9,10 Although beta cell mass continues to expand in neonates, the net beta cell mass remains unchanged because of a concomitant wave of apoptosis, which in rodents, occurs around the weaning period, and in humans, around the time of birth.11,12 Neonatal beta cell apoptosis is part of a physiologic program to remodel the endocrine pancreas4,12 and may further serve as a quality-control mechanism to select for a functional pool of beta cells with appropriate insulin secretion response to glucose.13,14,15 Persistent beta cell proliferation and apoptosis beyond the neonatal phase of pancreatic development was recently found in biopsies of newborns and children with hyperinsulinism and hypoglycemia of infancy,11 a metabolic disorder in which the lack of proper neonatal beta cell mass remodeling interferes with the fetal to adult beta cell transition, leading to retention of fetal beta cells incapable of eliciting an insulin secretory response that matches the level of glycemia.16 The molecular mechanisms controlling the change in apoptotic rate during fetal to neonatal beta cell transition are not fully understood. Direct correlations exist between the wave of apoptosis and expression
201
202 |
NIKA N. DANIAL |
pattern of multiple cell death/survival molecules in the developing pancreas. Notably, the antiapoptotic BCL-2 protein and the inhibitor of apoptosis protein survivin, which inhibits caspase-3 and -9,17 display high expression levels in fetal beta cells but are undetectable in the postnatal period.18,19 Furthermore, the neonatal wave of apoptosis is marked by high expression of the dephosphorylated, apoptotically active form of the BCL-2 family protein BAD.20,21,22 This is consistent with the observation that insulin-like growth factor (IGF) II, a known beta cell survival factor that targets BAD phosphorylation23 and stimulates beta cell survival,24 declines during neonatal pancreatic development.25,26,27 Of note, low levels of fetal IGF-II levels are associated with elevated beta cell apoptosis and gestational diabetes due to maternal diet low in proteins.28
In the adult, beta cell mass is linearly proportional to body weight29 and is under tight homeostatic control so that insulin secretion is proportional to insulin demand. Apoptosis influences the beta cell mass dynamics in the adult. For example, a 2.5-fold increase in beta cell mass during pregnancy30,31 is followed by rapid and efficient involution of beta cell mass postpartum because of a significant increase in apoptosis.32 Similarly, increase in beta cell function33,34 and mass35,36,37,38 during weight gain associated with obesity is an adaptive response to compensate for obesity-induced insulin resistance, a state in which liver and peripheral tissues such as muscle and fat become less sensitive to the action of this hormone and more insulin is needed to preserve euglycemia.39,40 In addition to increased proliferation and beta cell hypertrophy, attenuated apoptosis contributes to obesity-induced beta cell mass expansion.41,42,43 Studies are just beginning to unravel the functional relevance of the intrinsic and extrinsic pathways of apoptosis in beta cell mass adaptation. As such, genetic models have provided evidence that BAD36,44 and caspase-845 are but two apoptotic modulators of obesity-associated beta cell mass expansion. The importance of this homeostatic response of beta cell mass to insulin resistance is underscored by the fact that its insufficiency is associated with type 2 diabetes46,47,48,49 as detailed in the following sections.
3. CONTRIBUTION OF APOPTOSIS TO BETA CELL
MASS INADEQUACIES IN DIABETES
Loss of functional beta cell mass is central to the etiology of both type 1 and type 2 diabetes.35,50,51,52 Although the distinction between these two disease subtypes is based on differences in the nature of beta cell failure, the time of disease onset, and genetic predisposition,
accumulating evidence suggests that the common features between these two subtypes are more numerous than previously anticipated. Indeed, beta cell apoptosis is a common end point in both subtypes, which is further influenced by genetic and environmental factors. In type 1 diabetes (T1D), absolute insulin deficiency is due to the autoimmune-mediated loss of beta cells and the associated inflammatory immune response.52 In type 2 diabetes (T2D), beta cell apoptosis is induced by metabolic stress that accompanies chronic exposure to elevated levels of glucose and saturated fatty acids, oxidative stress, and endoplasmic reticulum (ER) stress because of accumulation of unfolded proteins.8,53,54,55 Recent studies also show that the damage inflicted by inflammatory cytokines is not unique to T1D; rather the metabolic stress imposed on beta cells in T2D leads to their secretion of inflammatory cytokines and subsequent cytotoxicity.56 The following sections review the beta cell defect and apoptotic stimuli in each diabetes subtype.
3.1. Beta cell death in the development of T1D
T1D is marked by autoimmune destruction of islet beta cells by cytotoxic T-lymphocytes (CTLs) that recognize beta cell–derived self-antigens. Progression of the type 1 disease follows a series of histopathologically defined stages that includes infiltration of lymphocytes in the area surrounding the islets of Langerhans, also known as insulitis, followed by production of inflammatory cytokines and fulminating immune attack.52 Permanent loss of functional beta cell mass is accompanied by blunted insulin secretion, glucose intolerance, and insulin dependency for life. Although characterization of the type 1 disease in humans has been limited to in vitro islet cultures and gene expression profiling of different disease stages, mouse models of the disease, especially the nonobese diabetic (NOD) mouse, as well as multiple T cell receptor TCR transgenic lines, have proved instructive in uncovering some of the molecular mechanisms underlying the breakdown of immune barrier and the cellular and molecular components of beta cell destruction.57 However, despite multiple common elements in disease progression, the extent to which modeling of the type 1 disease in rodents phenocopies that in humans is not fully understood.
Autoantigens in T1D consist of beta cell–derived peptides that are most likely encountered during the wave of neonatal beta cell apoptosis.58,59,60 Antigen presenting cells (APCs) such as macrophages and dendritic cells engulf apoptotic beta cells and process and present beta cell–derived peptides that include, but may not